Daiichi Sankyo wants a big piece of India’s biggest drug-maker.
Tokyo-based Daiichi is looking for a majority stake in Ranbaxy Laboratories and is willing to pay a 31.4% premium to get it. The purchase, if it goes through, would include the founding family’s 34.8% stake, the WSJ reports. Daiichi would buy up to another 20% of [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment